Search research articles
Contact Us
Filters
Showing results (571-580 of 670) with videos related to
Page
of 67
Sort By:
Cardiovascular Research
|
August 22, 2022
SGLT-2 inhibition by empagliflozin has no effect on experimental arterial thrombosis in a murine model of low-grade inflammation
Luca Liberale, Simon Kraler, Yustina M Puspitasari, et al.
American Heart Journal Plus : Cardiology Research and Practice
|
April 1, 2024
Insights to advance our management of myocardial ischemia: <i>From obstructive epicardial disease to functional coronary alterations</i>
C Noel Bairey Merz, John F Beltrame, Colin Berry, et al.
Vascular Pharmacology
|
July 19, 2024
Antithrombotic properties of Tafamidis: An additional protective effect for transthyretin amyloid cardiomyopathy patients
Stefano Ministrini, Rebecca Niederberger, Alexander Akhmedov, et al.
International Journal of Cardiology
|
March 15, 2025
Clinical standards in angina and non-obstructive coronary arteries: A clinician and patient consensus statement
Colin Berry, Paolo G Camici, Filippo Crea, et al.
European Heart Journal
|
January 10, 2017
Ticagrelor, but not clopidogrel active metabolite, displays antithrombotic properties in the left atrial endocardium
Martin F Reiner, Alexander Breitenstein, Erik W Holy, et al.
International Journal of Cardiology
|
July 16, 2018
Corrigendum to 'Sirtuin 5 as a novel target to blunt blood-brain barrier damage induced by cerebral ischemia/reperfusion injury' [Int. J. Cardiol. 260 (2018) 148-155]
Candela Diaz-Cañestro, Mario Merlini, Nicole R Bonetti, et al.
Thrombosis Research
|
December 16, 2018
Gut microbiota-dependent trimethylamine-N-oxide (TMAO) shows a U-shaped association with mortality but not with recurrent venous thromboembolism
Martin F Reiner, Daniel Müller, Sara Gobbato, et al.
International Journal of Cardiology
|
April 30, 2020
Myocardial ischemia: From disease to syndrome
Mario Marzilli, Filippo Crea, Doralisa Morrone, et al.
Kidney International
|
May 9, 2018
The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease risk
Eva-Maria Pastor-Arroyo, Nicole Gehring, Christiane Krudewig, et al.
Cardiovascular Research
|
February 16, 2017
Endothelial LOX-1 activation differentially regulates arterial thrombus formation depending on oxLDL levels: role of the Oct-1/SIRT1 and ERK1/2 pathways
Alexander Akhmedov, Giovanni G Camici, Martin F Reiner, et al.
Page
of 67
Search research articles
Search
Showing results (571-580 of 670) with videos related to
Sort By:
Page
of 67
Cardiovascular Research
|
August 22, 2022
SGLT-2 inhibition by empagliflozin has no effect on experimental arterial thrombosis in a murine model of low-grade inflammation
Luca Liberale, Simon Kraler, Yustina M Puspitasari, et al.
American Heart Journal Plus : Cardiology Research and Practice
|
April 1, 2024
Insights to advance our management of myocardial ischemia: <i>From obstructive epicardial disease to functional coronary alterations</i>
C Noel Bairey Merz, John F Beltrame, Colin Berry, et al.
Vascular Pharmacology
|
July 19, 2024
Antithrombotic properties of Tafamidis: An additional protective effect for transthyretin amyloid cardiomyopathy patients
Stefano Ministrini, Rebecca Niederberger, Alexander Akhmedov, et al.
International Journal of Cardiology
|
March 15, 2025
Clinical standards in angina and non-obstructive coronary arteries: A clinician and patient consensus statement
Colin Berry, Paolo G Camici, Filippo Crea, et al.
European Heart Journal
|
January 10, 2017
Ticagrelor, but not clopidogrel active metabolite, displays antithrombotic properties in the left atrial endocardium
Martin F Reiner, Alexander Breitenstein, Erik W Holy, et al.
International Journal of Cardiology
|
July 16, 2018
Corrigendum to 'Sirtuin 5 as a novel target to blunt blood-brain barrier damage induced by cerebral ischemia/reperfusion injury' [Int. J. Cardiol. 260 (2018) 148-155]
Candela Diaz-Cañestro, Mario Merlini, Nicole R Bonetti, et al.
Thrombosis Research
|
December 16, 2018
Gut microbiota-dependent trimethylamine-N-oxide (TMAO) shows a U-shaped association with mortality but not with recurrent venous thromboembolism
Martin F Reiner, Daniel Müller, Sara Gobbato, et al.
International Journal of Cardiology
|
April 30, 2020
Myocardial ischemia: From disease to syndrome
Mario Marzilli, Filippo Crea, Doralisa Morrone, et al.
Kidney International
|
May 9, 2018
The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease risk
Eva-Maria Pastor-Arroyo, Nicole Gehring, Christiane Krudewig, et al.
Cardiovascular Research
|
February 16, 2017
Endothelial LOX-1 activation differentially regulates arterial thrombus formation depending on oxLDL levels: role of the Oct-1/SIRT1 and ERK1/2 pathways
Alexander Akhmedov, Giovanni G Camici, Martin F Reiner, et al.
Page
of 67